# Rhône-Poulenc Chemie, Roussillon, France – FDA Inspections

Source: https://www.keypedia.com/companies/rhone-poulenc-chemie/a6b817d4-60fc-4752-86e3-d88cb3fc260f

> Inspection records and compliance data for Rhône-Poulenc Chemie in Roussillon. Access full analysis and detailed observations.

---

## Details

- Name: Rhône-Poulenc Chemie
- FEI Number: 3002927231
- Address Line 1: Rue Gaston Monmousseau
- City: Roussillon
- Country Name: France
- Address: Rue Gaston Monmousseau, Roussillon, France
- Country: France

## Related Documents

- [483 - Rhône-Poulenc Chemie - 1997-07-08](https://www.keypedia.com/records/483/rhone-poulenc-chemie/038b6d17-0fdb-4a60-be52-f9ba5b6c78ee) — source: FDA, date: July 8, 1997

## Related Companies

- [Vipamat Technologie](https://www.keypedia.com/companies/vipamat-technologie/d41fea06-e10a-4aec-b221-dd5dfc8da954)
- [Orlane S.A.](https://www.keypedia.com/companies/orlane-sa/d94e44bf-ec9c-49b4-a425-f30f9372d6e7)
- [Calaire Chimie S.A.S.](https://www.keypedia.com/companies/calaire-chimie-sas/56619e1e-de2a-4ab6-af8b-332a5c6b5714)
- [Excelvision - Fareva](https://www.keypedia.com/companies/excelvision-fareva/7da66fe3-8945-4c51-bf6c-2f63015c728a)
- [Pierre Fabre Medicament Production](https://www.keypedia.com/companies/pierre-fabre-medicament-production/a5269a54-f9eb-43ee-b590-5fcfe7668e3a)
- [AB Science](https://www.keypedia.com/companies/ab-science/3f308e3c-9b42-4f96-a47a-1ad9b8ead53a)
- [Societe Fromagere de Bouvron,](https://www.keypedia.com/companies/societe-fromagere-de-bouvron/f7ab8321-cdd4-489a-b4b7-adc20250768a)
- [ELA Medical S.A.S.](https://www.keypedia.com/companies/ela-medical-sas/f0c765b6-353b-454a-8dc1-8140c6c50361)
- [Biotech International](https://www.keypedia.com/companies/biotech-international/71aa7b07-34dd-4142-8195-7ad601172f53)
- [TruAbutment Inc.](https://www.keypedia.com/companies/truabutment-inc/1ecee788-1e28-4d4f-b997-8bc72059f5fc)

## Related Officers

- [Paraluman S. Leonin](https://www.keypedia.com/people/paraluman-s-leonin/84af7735-ac9c-4e37-a708-94cbe834cec8)
